The perturbation of membrane immunoglobulin (mIg)' on B lymphocytes can have diverse effects on B cell physiology. Immature B cells and certain activated B cell populations are particularly susceptible to inhibition (tolerance) after mIg crosslinking (1-4), while mature, resting B cells are characteristically stimulated to DNA synthesis (4-6) . Because both stimulatory and inhibitory signal transduction appear to involve similar early biochemical reactions (1, 6), it is of some interest that the ligand dose requirements for achieving these distinct functional phenomena have generally been found to differ by one or more orders of magnitude (3, (7) (8) (9) (10) . This suggests that the ligand binding requisites for triggering B cell tolerance may be significantly different from those for directly triggering B cell clonal expansion .
patients with chronic lymphocytic leukemia (CLL). Kon and Lub cells were from patients with hairy cell leukemia (HCL) and have been described elsewhere (16) . At the time of sampling, all donor patients had peripheral white blood cell counts ;o 262,000 cells/mm3 with little or no contamination with nonleukemic cells, as confirmed by indirect immunofluorescence staining with T cell, monocyte, and B cell-specific mAb probes (16) . FACS analysis of these leukemias with Ig heavy and light chain-specific mAbs and a fluorescein-conjugated goat F(ab)2 anti-mouse Ig probe revealed the following membrane Ig phenotypes : Bia (p, 8, X), Lan (p, 8, x) , Kon (p, 8, x) , and Lub (p, 8, x) . The B lymphoblastoid cell line Daudi (tt, 8, x; American Type Culture Collection, Rockville, MD) was also used for some ligandbinding experiments . With the exception of Daudi, cells from each source were frozen at the same time in multiple aliquots and stored in the vapor phase of liquid nitrogen .
Cell Culture Conditions and T Cell Factors. T cell-depleted splenocytes and leukemic B cells were cultured at 2-2 .5 x 105 cells per well in a volume of 0 .2 ml as previously described (11, 16) . DNA synthesis was assessed by uptake of an 18-h pulse of 1 pCi [sH]thymidine (72 .5 Ci/mmol; New England Nuclear, Boston, MA). Where raw data are illustrated, mean (X) cpm f SEM from three identical cultures are reported . Data indicated as A cpm represent the difference between the cpm in test vs. control cultures . Index of stimulation (SI) values represent the quotient obtained by dividing the cpm measured in test wells by the cpm observed in control cultures .
Activated T cell supernatants containing growth factors for B cells were obtained from cultures of PHA-stimulated mixtures of peripheral blood cells of allogeneic individuals as described previously (11, 16) . In some experiments, a partially purified B cell growth factor (BCGF) preparation was used (Cellular Products, Inc ., Buffalo, NY) .
Propidium Iodide Analysis. The DNA content of individual nuclei from cultured Kon leukemic cells was measured with the FACS IV using propidium iodide (PI) as a marker (5) . Briefly, cells were centrifuged and stained with 50 pg/ml PI (Sigma Chemical Co .) in 0 .1°Jo sodium citrate and 0 .1% NP-40 detergent (Sigma Chemical Co.). Approximately 10,000 nuclei from each sample were analyzed . Debris was excluded from analysis by gating based upon forward light scatter. The amount of DNA was assessed by the level of fluorescence emission at 608-655 nm after excitation at 488 nm. Segregation of cells in Go (GI) vs . S, G2, and M was based upon slope extrapolation as described (18) . Go (G,) cells were considered to be those falling between the gates set by linear extrapolation of the ascending and descending limbs of each diploid cell peak to baseline. Cells above the upper gate of the diploid peak were considered to be in S, G2, or M .
Equilibrium-Binding Analysis. Assays used the phthalate oil method of separating cell-bound from free ligand (19) . Before assay, cells were enriched for viability (generally >95%) by centrifugation through Ficoll/Hypaque at 4'C . The number of cells used varied, depending upon the mIgM density of the cell population, the specific activity of the mAb Fab! fragment, and its affinity for IgM . Assays with Bia cells used 1 .3-3 .6 x 10'/ml ; those with Dau = 1 .2-2 .5 x 10' ; Lan = 0 .6-1 .8 x 10'/ml ; Lub = 2 .5-11 .9 x 10'/ml ; and KE37 = 2 .5 x 10'/ml . Before each experiment, iodinated mAb Fab' fragments were ultracentrifuged at -100,000 g for 8 min (Beckman Airfuge, Beckman Instruments, Inc ., Fullerton, CA) with the top onehalf used for analysis .
The equilibrium-binding experiments were performed as follows : 2 :3 serial dilutions of iodinated mAb Fab' fragments in assay medium (DMEM + 1% BSA + 15 mM sodium azide with 50 mM 2-deoxy-D-glucose to block potential ligand internalization [20] ) were added to cells in medium precoated 400-p1 Eppendorf tubes to a final vol of 200 pl . Triplicates were run when label was used alone, and duplicates were used for assessing background binding (see below). The tubes were slowly rotated at 4°C until equilibrium was reached at 2 h, i.e., when a twofold increase in reaction time resulted in a <10% increase in bound ligand (21) . After incubation, 150 pl of the cell mixture was gently layered over 150 pl of precooled phthalate oils (2 :1 vol/vol mixture of dibutyl/dioctyl phthalate [Kodak]) in 7 x 50 mm (400 pl) polyethylene microfuge tubes (Beckman Instruments, Inc .) and centrifuged in a microfuge (Beckman Instruments, Inc.) at 12,000 g for <1 min at 22'C. Separation of the cell pellet from the nonbound ligand in the aqueous layer was achieved by freezing the tubes at -70'C and sawing off the tube tip . The cell-bound cpm in the pellet was determined with a gamma counter. The data were analyzed by the LIGAND computer program (22) to give the equilibrium binding constants (K. in 1/mol or M -') and the number of epitopes bound by mAb Fab' ligand, in addition to the percent coefficient of variance of these values (22) .
Nonspecific binding of label to cells was always determined in two different ways: (a) by assaying the binding of ligand to cells in tubes containing a 100 :1 pM ratio of pentamer IgM to Fab' ligand and (b) by measuring the binding of iodinated Fab' fragments to the Tlymphoblastoid cell line, KE37 . Both gave comparable background levels . In addition, in many experiments, unlabeled Fab' was substituted for pentameric IgM, yielding similar results .
Immunoekctron Microscopy. Techniques detailed elsewhere were used (23, 24) . Briefly, freshly cleaved mica sheets, onto which a thin film ofcarbon was coated, were serially floated onto : a 1 % tryptophan solution; H2O; mAb F(aU)2 fragments, IgM monomer, or their immune complexes in 0 .15 M ammonium acetate ; 0 .3 M ammonium acetate ; and a 2 % uranyl formate staining solution. Monomeric IgM and F(aU)2 antibody were diluted in 0 .5 M acetate to yield a 1 :1 ratio at 1-3 gg/ml total protein. All reagents were placed as large droplets onto a Teflon ring slide and kept at 4°C. The polished down side of a copper grid was gently placed upon the carbon film floating on top of the stain . After insuring that the carbon membrane adhered to the grid, the grid-membrane complex was quickly removed from the surface of the staining well, and excess stain was removed by capillary action . In such a procedure, the carbon membrane folds back upon itself and thus traps a thin film of stain between two folds of the protein-coated film on the grid . The grids were examined on aJEOL CEM CX100 electron microscope and photographed at 100,000 diameters magnification . Negatives were printed at a total magnification of x 260,000 for analysis.
Results
Domain and Epitope Specificity of Murine Anti-Human IgM mAbs. Table I lists the murine anti-human IgM mAbs used in this study and shows the p chain domain specificity as well as the likely number of unique epitopes bound by these mAbs.
Evaluation of Anti-IgM mAb Affinity for Human mIgM. Results from equilibriumbinding experiments, performed at 4°C with four different IgM + clonal B cell Because of lesser reliability of cell binding data from low affinity ligands, mAbs P19, P24 and 1F11 have been excluded from this analysis . The number of epitopes per cell is equal to the number of Fab' molecules bound per cell at saturation as derived from the Scatchard plot . $ The number of epitopes per mIgM molecule was calculated by normalizing all n x 10 -4 values to that of XG9 Fab' on the basis that this latter Cpl-specific mAb binds to two epitopes per mIgM molecule . The formula used was the following : normalized number of epitopes per mIgM molecule for mAb x = [(number of bound epitopes per cell observed with x) x 2]/number of bound epitopes per cell observed with mAb XG9 . I I In instances in which >1 equilibrium binding experiment was performed, the average n t SEM are given .
Numbers in parentheses indicate the percent CV of the n value(s) .
cell population of 21.3 t 5.6%. One mAb, XG9, consistently had a significantly lower affinity on Lub leukemic cells (1.03 t 0.31 x 10' M-1) than on the remaining three cell populations (mean Ka = 6.95 t 1.59 x 10' M-1). Ka values for the lower affinity mAbs (P19, P24, and IF11) were determined with less precision in part because only Dau and Lan, expressing high-density mIgM, yielded useful data and in part because fewer data points fulfilled the requirement of being 100-fold above the background binding with excess IgM (21) .
Others have previously noted that increases in temperature can either increase or decrease the measured equilibrium binding constant (27, 28) . The available data do not allow us to determine whether the mAb intrinsic affinities measured at 4°C are identical or different from those that occur at 37°C.
Analysis ofthe Stoichiometry ofmAb Fab' Binding to mIgM. The total number of IgM epitopes per cell bound by the Fab' fragments at ligand saturation (n) (22, 29, 30) is shown in Table III . With the clear exception ofmAb 5137, and the possible exception of mAb Mu18, all of the evaluated mAbs bound to a comparable number of epitopes within each of the cell populations tested . 5137 consistently bound to an epitope expressed with a two-to threefold greater frequency. This difference is significant since replicate determinations with 5137, made on the same cell population but on separate days, resulted in an average variation of35 t 7 % (X t SEM, range = 2-63%). The multiple epitopes bound by mAb 5137 Fab' appeared to be identical since all derived Scatchard plots were generally linear and conformed to a one-site model when evaluated by the LIGAND computer program (22) topes bound per mIgM molecule, based upon the assumption that the Cpl-specific mAb XG9 binds to two determinants per molecule . This was considered a valid supposition because the two Cpl domains are spaced widely apart on the Fab arms of monomeric IgM (31) and because immunoelectron microscopic data, to be presented later, supported the existence of a XG9-binding determinant on each FabP arm. By this analysis, the Cu2-specific r Abs HB57 and Mu53, and the Cp4-specific mAbs 4-3 and 1G6, apparently bind to divalendy expressed determinants on mIgM, the epitopes presumably arising from each of the two p chains that make up the intact IgM molecule . The Cw4-specific mAb 5137 appeared to recognize an epitope with a valency of 4-6 per mIgM molecule (i .e., 2-3 per u heavy chain) . The Cp2-specific mAb Mu18 was consistently calculated to bind to <2 but >1 epitopes per mIgM molecule. This latter finding may reflect steric hindrance or induced changes in conformation that reduce Mu18 Fab access to the second epitope.
Relationship of Anti-IgM Domain Specificity to Mitogenic Potentialfor Human B Splenocytes. Fig. 1 indicates that, in the presence of 30% T cell supernatant as a source of ancillary growth factors, neither of the Cg1-specific mAbs, directed to two distinct epitopes, were able to elicit substantial B cell DNA synthesis at any dose tested (concentration range: 2-1,000 wg/ml) . An additional seven Cwl-specific mAbs that have been defined as binding to the same epitope or a contiguous determinant to that of mAb XG9 (12) also are nonmitogenic or only weakly mitogenic for human B cells (11 ; data not shown) . In contrast, all but one of the Cut-binding mAbs tested induced substantial DNA synthesis, although the doses required to induce proliferation varied considerably. Of the four Cp4-directed mAbs, 5137 was exceptionally mitogenic at low ligand concentrations; mAb 4-3 required high ligand concentrations for significant B cell stimulation ; and mAbs 1G6 and 1711 were only very weakly mitogenic at the highest doses tested .
The above data indicate that while soluble anti-IgM mAbs of Cpl-domain specificity are impaired in their capacity for triggering human B cell DNA synthesis, the binding of mAbs to either Cpl or membrane-proximal Cw4 can result in significant B cell proliferation. Since not all mAbs to CO and Cu4 elicited the same degree of stimulation, binding characteristics other than IgM domain specificity must play a critical role in determining mitogenic potential.
Relationship ofAnti-IgM mAbAffinity to Ibtentialfor Triggering B Cell DNA Synthesis. Fig.  2 describes the capacity of individual mAbs of differing affinities to stimulate in vitro B cell DNA synthesis at either low (10-20 ug/ml) or high (100-300 wg/ml) concentrations . The mean SI achieved by divalent antibodies is plotted as a function of their intrinsic Fab affinities. At low concentrations, only the two highest affinity antiIgM mAbs, i.e ., HB57 and 5137 (Ka = 5.3 and 1.2 x 10 8 M-1 , respectively) induced significant DNA synthesis (Fig. 2 A) . Greater concentrations compensated for diminished ligand affinity and allowed for induction of DNA synthesis by antibodies with intrinsic affinities of 0.37-4.66 x 10' M-1 (Fig . 2 B) . mAbs with Ka of <0 .37 x 10' M-I were nonstimulatory, even at high ligand concentrations . With the notable exception of mAb XG9, a direct relationship was observed between mAb binding affinity and stimulatory potential. A least squares linear regression analysis (excluding mAb XG9 and the lowest affinity antibody IF11), yielded a regression line of r = 0.985 .
Monogamous Binding Interactions of mAb XG9 with Monomeric IgM. Immunoelec- tron microscopy was used to evaluate the possibility that Cpl-specific XG9 mAb might bind to monomeric IgM in a monogamous fashion (30), i.e., both binding sites of a single XG9 Ab molecule engaged with epitopes on a single IgM molecule . Such a finding could explain the nonmitogenic nature of high-affinity mAb XG9, since ahigh proportion of monogamous binding would reduce the amount ofmIgM crosslinking . Fig. 3 (panels BI-4 and C1-3) show that XG9 F(ab')2 can indeed bind monogamously to monomeric IgM (72% of the observed complexes). The remaining complexes had either one XG9 F(ab')2 bound to two monomeric IgM molecules in a bigamous manner, or alternatively, XG9 F(ab')2 molecules bound to IgM monomer via one arm only (data not shown) . The monogamously bound XG9 F(ab')2 Effect of mAb affinity upon ability to inhibit leukemic B cell DNA synthesis. The concentration of intact mAb required for 50% inhibition of leukemic B cell [3Hlthymidine incorporation was calculated from dose-response profiles obtained from at least two separate experiments on both Kon and Lub HCL B cells (Fig . 4) . The mean values are plotted as a function of mAb Fab' affinity in M-1. In the case of Lub cells, mAb XG9 is indicated as having a lower affinity, XG9*, than on Kon cells (see legend Table II ). The composite data indicate that the inhibition of leukemic B cell DNA synthesis by intact antibody is relatively independent of affinity, until an Fab' affinity threshold of ti7 x 10 6 M-' . molecules appeared to have more compacted dimensions than when found in free, nonbound form. This has been previously noted with anti-K mAb binding to mouse IgG molecules (23) and is considered to be due to geometric constraints that prevent the immune complex from lying on the same flattened plane.
Panels DI-4 and EI-4 of Fig. 3 show the contrasting types of complexes observed between monomeric IgM and the F(ab')2 fragment of the CV4-specific mAb 1G6. The results clearly indicate the bivalent nature of the 1G6 epitope. Of the immune complexes formed, >75% had two 1G6 F(ab')2 molecules bound per IgM monomer (panels D3 and 4 and E2-4), whereas the remainder of observed immune complexes had only one F(ab')2 bound per molecule of monomer (panels DI and 2 and EI ). Monogamous binding of 1G6 F(ab')2 to monomeric IgM was not detected .
Inhibition of Leukemic B Cell DNA Synthesis by mAbs Having Cul-, Cut-, and Cu4-binding Specicities. The ligand-binding requisites for inhibitory signal transduction were evaluated with two human HCL B cell populations previously shown sensitive to anti-IgM-mediated negative signaling (16) . These are: Kon, which can be induced to in vitro DNA synthesis by T cell factor-containing supernatant, and Lub, which synthesizes DNA spontaneously (Fig. 4) . All mAbs, irrespective of their IgM domain specificity, were found to signal inhibition of Kon and Lub leukemic B cell DNA synthesis at ng/ml concentrations. This signaling required mIgM crosslinking and did not involve Fc-receptor binding (16) .
Amity RequirementforAnti-IgM-mediated Inhibitory Signaling. Fig. 5 shows that the diversity in the inhibitory potential of certain mAbs reflects their affinity for mIgM. mAbs that required significantly greater amounts of ligand to achieve 50% inhibition of leukemic B cell DNA synthesis, i.e ., P19, P24, and IF11, had the lowest affinities for mIgM . While a direct relationship was noted between affinity of these three ligands and inhibitory potential, concentration-dependent differences in inhibition by mAbs with Fab' binding affinities >7 .0 x 106 M-1 were not evident . This suggests an affinity threshold for inhibitory signaling by anti-Ig ligands, above which increases in affinity have a minimal effect . Also notable in Figs . 4 and 5 is that mAb XG9 was not notably compromised in causing inhibition despite its established propensity for monogamous binding (Fig . 3) .
Binding Requisites for Stimulatory and Inhibitory Signal Transduction Differ in a Clonal
B Cell Population. The above cumulative data suggest that the ligand binding requisites for triggering inhibition of DNA synthesis through mIgM are significantly less demanding than those for stimulating DNA synthesis . Because stimulation was evaluated with normal B lymphocytes and inhibition was evaluated with leukemic B cell clones, normal vs. malignant cell phenotype may have accounted for the distinctions . That this is not the case is shown in experiments with an unusual HCL clone, Kon, which can receive stimulatory, or alternatively, inhibitory signals from antiIgM ligands, depending upon its state of activation (16) . In the absence of T cell factors, Kon cells respond with very significant levels of DNA synthesis only to high concentrations of the highest affinity mAb, HB57 (Table IV ) (16 ; data not shown).
In striking contrast, the T cell factor-induced DNA synthesis of the clone is inhibited by low as well as high doses of all the anti-IgM ligands (Table IV ; Fig . 4 ) . These data with a clonal B cell population clearly indicate that the differences in ligand requisites for activating and inhibiting B cell DNA synthesis are not simply reflective of the malignant vs . normal nature of the cell populations used, but, rather, represent distinct mIg binding requirements for inducing the two functional outcomes . Discussion One principal conclusion of these studies is that the induction of human B cell DNA synthesis, a requisite for B cell clonal expansion, is primarily determined by the affinity of the mIgM crosslinking ligands . With one explainable exception, a direct relationship was noted between the intrinsic affinity of a mAb for mIgM and its mitogenic potential . At high ligand concentrations (100-300 ug/ml), the minimal affinity threshold for inducing significant B cell DNA synthesis in the presence of ancillary T cell factors was Ka = -2 x 10' M-1 . At lower ligand concentrations (10-20 ug/ml) this threshold was significantly greater, i.e ., Ka = -1 x 108 M-1 . This is as predicted given the law of mass action effect of concentration of reactants on complex formation (21) . Because stimulatory signal transduction by anti-Ig antibodies requires bivalent binding of the ligand (6), and because bivalent mAb binding to cell membrane antigens is characterized by at least a 10-100-fold enhancement in avidity over that exhibited by univalent Fab`fragments (28, 29) , it is anticipated that the minimal binding avidity of a soluble anti-IgM ligand required for inducing human B cell DNA synthesis at high concentrations is in the range of 2 x 108-9 M-1 , and at low concentrations is in the range of 1 x 10 9'1°M-1 . Our findings that affinity is a major contributing factor to ligand stimulatory capacity supports and extends in a quantitative way the findings of Goroff et al . (32) with anti-mouse IgD mAbs .
The only ligand that deviated from a direct linear relationship between intrinsic affinity and proliferation-inducing capability was mAb XG9. This relatively highaffinity antibody (Ka = 6.95 x 107 M-1 ) was consistently nonmitogenic for normal human B cells, even at concentrations up to 1 mg/ml. Immunoelectron microscopy provided an explanation by revealing that mAb XG9 has a predilection for monogamous binding to the bivalently expressed CAI epitopes on monomeric IgM. This tendency is probably due to the comparable spacing between CAI epitopes and the bivalent combining sites of the mAb. It is highly likely that monogamous binding diminishes the stimulatory signaling potential of this high-affinity antibody by reducing its crosslinking potential.
The functional data shown here, as well as capping studies (our unpublished results), suggest that Cg2-and Cg4-specific antibodies have a lower probability of engaging in monogamous binding interactions with mIgM than Cg1-specific antibodies . Monogamous binding may be precluded by the close interactions between homologous pairs of the Cg2 and Cg4 domains (31) as well as by the predicted topographically polar orientation of epitopes on each side of the globular paired domain structures. The findings of Goroff et al . (32) that high-affinity mAbs directed to the Fd portion of murine IgD were ineffective at capping and stimulating mouse B cell DNA synthesis, whereas high affinity mAbs to the Fc portion of murine IgD were good at inducing capping and very mitogenic, are also explainable in this context. These findings have strong functional implications for antiidiotype antibodies, since monogamous binding appears to be characteristic of a substantial proportion of andidiotype mAb interactions with both soluble and cell-bound Ig molecules (24, 28, 33) . Those antiidiotype antibodies of the IgG class that bind monogamously to m1g should be significantly impaired in capacity for directly inducing B cell clonal expansion, regardless of their affinity for their respective epitopes .
Among the hypotheses initially considered for the diversity in mAb stimulatory signaling potential was the valency of mIgM epitopes recognized by each mAb. Differences in the epitope univalency (34) or divalency were expected to have significant effects on the extent to which mIgM molecules could be crosslinked, i.e ., dimer formation vs . linear concatemer formation (30) . The studies shown here on Fab binding stoichiometry to m1gM exclude this hypothesis, since with one exception, all of the anti-IgM mAbs appeared likely to bind bivalently expressed epitopes .
The Cg4-specific mAb, 5137, was unique in its recognition of an epitope with an apparent valency of 4-6 per mIgM molecule . Because the hybridoma cloning conditions, the unusual isotype of this mAb, and the unusual enzymatic fragmentation characteristics of 5137 all attest to its monoclonality, we do not consider that the antibody preparation represents a mixture of antibodies to distinct determinants . Further characterization of the 5137 epitope is in progress.
Of great significance in these studies was the fact that the conclusions regarding mIgM ligand-binding requisites for stimulation of B cell DNA synthesis did not apply to inhibition . First, consistent with other studies (3, (7) (8) (9) (10) , the ligand concentrations for maximal inhibition of B cell DNA synthesis were orders of magnitude lower than those for stimulation . Second, while inhibitory signaling was clearly affinity independent at univalent ligand affinities >7 .0 x 10 6 M-1 , an upper affinity threshold for maximal stimulation of B cell DNA synthesis was not detected . Third, while a high-affinity Cg1-specific mAb with a propensity for monogamous binding to mIgM was unable to initiate B cell DNA synthesis, the same antibody was quite competent at causing inhibition. These distinctions indicate that the ligand binding requisites for mIgM-mediated inhibition of B cell DNA synthesis are much less rigorous than those for B cell clonal expansion and explain the past observations of Leptin (35) with anti-mouse IgM mAbs . Although inhibitory signaling was here studied with leukemic B cells, these observations have physiologic significance for normal B cells since the mechanism for mIgM-mediated inhibition in malignant B cells is thought to mimic that responsible for at least one form of B cell tolerance (1, 2, 36) .
Two major explanations appear plausible for the differences in binding requisites . First, stimulation of DNA synthesis may require a greater initial crosslinked receptor cluster, immunon (37), than inhibition . Thus, activation of susceptible cells may be achieved only with high-affinity ligands which, because of their likely lower dissociation rate (27) and prolonged occupancy, are more capable of stabilizing such clusters (see Fig. 6 A) . Alternatively, the greater binding requisites for stimulation may reflect the duration of the stimulatory signaling process (Fig. 6 B) . Our unpublished observations, as well as the work of others, have indicated that for S phase entry of anti-Ig-treated resting B cells, ligand must be present for an interval of 24-36 h (8, 38, 39) , while inhibition of DNA synthesis may be achieved after significantly shorter ligand exposure (36) . This difference becomes particularly relevant when one considers that, after an initial cycle of capping and endocytosis, B cells slowly replace mIg molecules and display very low-density mIgM for some time (38) . Under these conditions, continued B cell signaling by mIgM crosslinking may be achieved only by high-affinity ligands that can remain univalently bound to mIgM for a period of time sufficient for distally located mIgM molecules to diffuse into proximity. This hypothesis places greater demands on the ligands only at later phases in B cell activation .
Several recent observations from other laboratories lend support to this second explanation (Fig . 6 B) . First, anti-Ig ligands that are ineffective at inducing the DNA synthesis of resting B cells have been documented to initiate a number of early activation-related biochemical changes in B cells that precede, or are concurrent with, an initial cycle of mIg capping (18, 40) . Secondly, T cell factor-independent signaling of B cell DNA synthesis by high concentrations of polyclonal anti-IgM antibodies requires high ligand concentrations at late, but not early intervals in the stimulation of murine B cells (8, 39) .
Although it remains to be determined whether the binding requisites for inducing B cell tolerance are subtly different from those for inducing early activation related changes in resting mature B cells, the current data are compatible with the hypothesis that requirements for inducing any early biochemical phenomena in B cells with a comparable density of mIgM are the same . The inhibitory or stimulatory outcome of these early signals will depend upon the activation or differentiation state of the particular B cell population being studied (2, 3, 16) . For early pre proliferative changes in stimulated resting B cells to lead to clonal expansion, one of two events is necessary. There is (a) further signaling through mIgM crosslinking by ligands that can form stable complexes of mIgM under conditions of low m1gM density, and/or there is (b) signaling by activated class II MHC-restricted helper T cells or their products (6, 41) .
Our conclusion that tolerogenic signal transduction in susceptible B cells has much lower affinity requisites than signal transduction for B cell clonal expansion, would appear to contradict the conclusions of Riley and Klinman (42) in a murine experimental system . One major explanation may be that the former investigators evaluated B cell stimulation by antigens dependent upon cognate T cell help. The ligand binding requisites for sufficient B cell endocytosis, processing and presentation of epitopes to T cells, and stimulation of early Go-Go-changes such as increased m1a levels, which enhance B cell-T cell collaborative interactions, are likely much less demanding than the bindingrequisites for direct ligand-induced cell cycle entry (18, 43) .
physiological implications of our studies would appear to have the most immediate relevance to the direct, cognate T cell-independent signaling role played by autologous rheumatoid factors or antiidiotype antibodies in the regulation of B cell immune responses . Although IgG antiidiotype antibodies with a propensity for monogamous binding (24, 28, 33) may be compromised in their capacity to directly signal the clonal expansion of B lymphocytes, they may be active in negatively regulating the maturation or differentiation of idiotype-positive B cell clones. Furthermore, since most human rheumatoid factors appear to be ofrelatively low affinity (44) , it is expected that these ligands may manifest a more direct role in the feedback of B cell responses than in B cell clonal expansion. Summary The ligand binding requisites for membrane IgM-mediated signaling ofhuman B lymphocyte clonal expansion and B cell tolerance were investigated with a wellcharacterized set of soluble murine anti-human IgM mAbs. Evaluation of the impact oftt chain domain specificity, affinity, and binding stoichiometry for membrane IgM on antibody-induced regulation ofnormal and leukemic B cell DNA synthesis revealed that the ligand binding requisites for inducing or, alternatively, suppressing B cell DNA synthesis are significantly different . First, while the induction ofS phase entry required pglml concentrations of ligand, orders of magnitude lower concentrations ofligand sufficed for inhibitory signaling. Second, while an upper affinity threshold for achieving maximal stimulation of B cell DNA synthesis was never detected, inhibitory signaling by bivalent ligands appeared to become relatively affinity independent at Fab binding affinities >7.U x 1íï& M-'. Third, while a C1í2-specific mAb with an enhanced incidence ofmonogamous binding to m1gM was ineffective at inducing B cell DNA synthesis, the antibody was not significantly compromised in ability to initiate inhibitory signals. These differences could be observed in a clonal B cell population which positively or negatively responded to m1gM ligation de-: pending upon its state of activation. The accumulated observations indicate that the ligand binding requisites for inhibitory signal transduction in human B lymphocytes are much less rigorous than those for stimulatory signal transduction and sugogically relevant anti-Ig antibodies are more likely to function egative feedback regulation of B cell responses than in the direct triggering of human B cell clonal expansion .
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